Primary record
Spirostan-3-ol, (3ss,5ss,25S)-; 5ss-Spirostan-3ss-ol, (25S)- (8CI); Sarsasapogenin (6CI,7CI); Spiro[8H-naphth[2',1':4,5]indeno[2,1-b]furan-8,2'-[2H]pyran], spirostan-3-ol deriv.; (3ss,5ss,25S)-Spirostan-3-ol; NSC 1615; Parigenin; Sarsagenin
- 库存
- 4,791 克
- 纯度
- 99.2 %
- CAS
- 126-19-2
化合物标识与属性
- CAS
- 126-19-2
- PubChem CID
- 92095
- SMILES
- C[C@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@H]6[C@@]5(CC[C@@H](C6)O)C)C)C)OC1
- Canonical SMILES
- C[C@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC[C@@H]5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C
名称与同义词
- Sarsasapogenin
- Parigenin
- Sarsagenin
- sarsapogenin
- Sasarasapogenin
- 126-19-2
- Sarsapogenine
- Sarsasapogenenin
- cogan
- sarsagenina
- sarsagenine
- sarsageninum
- sarsasopogenin
- Sarsasapogenine
- Smilagenin
- Tigogenin
- Sarsagenin [INN]
- Sarsasapogenin;
- Parigenin;
- (25S)-5beta-Spirostan-3beta-ol
- Spirostan-3-ol
- Parigenin;Sarsagenin
- Sarsasapogenin, 95%
- PURE SARSASAPOGENIN
- AC1L3NEM
- RefChem:931315
- CFS802C28F
- Sarsasapogenin, >=98%
- UNII-CFS802C28F
- Spirostan-3-ol, (3beta,5beta,25S)-
- SARSASAPOGENIN [MI]
- Sarsapogenin (Sarsasapogenin)
- (25S)-Spirostan-3|A-ol
- C27H44O3
- CHEBI:15578
- NSC 1615
- (3b,5b,25s)-spirostan-3-ol
- SCHEMBL180164
- DTXSID00903921
- GMBQZIIUCVWOCD-WWASVFFGSA-N
- MFCD00270414
- Spirostan-3-ol, (3b,5b,25S)-
- (3beta,5beta,25S)-spirostan-3-ol
- orb1305096
- CHEMBL1171146
- NSC-1615
- EINECS 204-776-3
- GTPL13593
- (25S)-5EC-spirostan-3EC-ol
- DTXCID501331881
- KST-1A8673
- CID92095
- HY-N0073
- PYM50028
- ZINC8218968
- (3?,5?,25S)-Spirostan-3-ol
- 2770AC
- AR-1A4091
- BDBM50442865
- LMST01080007
- NP6105
- s3607
- (25S)-5-beta-spirostan-3-beta-ol
- 5beta-Spirostan-3beta-ol, (25S)-
- AKOS015960455
- Spirostan-3-ol, (3ss,5ss,25S)-
- (25S)-3beta-Hydroxy-5beta-spirostane
- ACN-035281
- C27-H44-O3
- CCG-208441
- CS-7949
- EBC-618396
- FS66596
- J5.383J
- Spirostan-3-ol, (3EC,5EC,25S)-
- (3-beta,5-beta,25S)-Spirostan-3-ol
- 4CN-0892
- AC-11191
- AC-33951
- AN-43560
- AS-77870
- BC201861
- SC-15309
- Spirostan-3-ol, (3|A,5|A,25S)-
- LS-193826
- A3192
- FT-0776978
- N1451
- NS00079370
- Resorufin-|A-D-glucuronide sodium salt, 98%
- Spirostan-3-ol, (3.beta.,5.beta.,25S)-
- C03963
- Spirostan-3-ol, (3beta,5beta,25S)- (9CI)
- (3.BETA.,5.BETA.,25S)-SPIROSTAN-3-OL
- SR-05000002243
- 82597-74-8
- A1200222
- Q7424590
- SR-05000002243-2
- SR-05000002243-3
- SR-05000002243-4
- BRD-K62277907-001-01-6
- Dihydro-1H-pyrrolo[1,2-c]imidazole-1,3,5(2H,6H)-trione
- (1R,2S,4S,5'S,6R,7S,8R,9S,12S,13S,16S,18R)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-16-ol
- (2aR,2'R,4S,5'S,6aS,6bS,8aS,8bR,9S,11aS,12aS,12bR)-5',6a,8a,9-Tetramethyldocosahydrospiro[naphtho[2',1':4,5]indeno[2,1-b]furan-10,2'-pyran]-4-ol
- (2aR,4S,5'S,6aS,6bS,8aS,8bR,9S,10R,11aS,12aS,12bR)-5',6a,8a,9-tetramethyldocosahydrospiro[naphtho[2',1':4,5]indeno[2,1-b]furan-10,2'-pyran]-4-ol
- 87498-44-0
- (1'R,2R,2'S,4'S,5S,7'S,8'R,9'S,12'S,13'S,16'S,18'R)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0?,?.0?,?.0??,??]icosane]-16'-ol
- (1'R,2R,2'S,4'S,5S,7'S,8'R,9'S,12'S,13'S,16'S,18'R)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosan]-16'-ol
- (1'R,2R,2'S,4'S,5S,7'S,8'R,9'S,12'S,13'S,16'S,18'R)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.02,9.04,8.013,18]icosan]-16'-ol
- (1R,2S,4S,5'S,6R,7S,8R,9S,12S,13S,16S,18R)-5',7,9,13-tetramethylspiro(5-oxapentacyclo(10.8.0.02,9.04,8.013,18)icosane-6,2'-oxane)-16-ol
- 204-776-3
- Spirostan-3-ol, (3ss,5ss,25S)-; 5ss-Spirostan-3ss-ol, (25S)- (8CI); Sarsasapogenin (6CI,7CI); Spiro[8H-naphth[2',1':4,5]indeno[2,1-b]furan-8,2'-[2H]pyran], spirostan-3-ol deriv.; (3ss,5ss,25S)-Spirostan-3-ol; NSC 1615; Parigenin; Sarsagenin